Authors
Loading...
Analysis reveals distinct TP53 mutations stratify patients in mantle cell lymphoma, suggesting varying prognostic outcomes.
Lingli Wang (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: